跳至主要内容
临床试验/JPRN-UMIN000020044
JPRN-UMIN000020044已完成1 期

Tadalafil treatment for Fetus with Early onset growth Restriction - Tadalafil treatment for Fetus with Early onset growth Restriction(TADAFER)

Department of Obstetrics & Gynecology Mie University Faculty of Medicine0 个研究点目标入组 12 人开始时间: 2015年12月3日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1) Patients with allergic to tadalafil 2) Patients are taking the drug, which is contraindicated to tadalafil 3) Patients are undergoing kidney dialysis, with severe renal impairment(creatinine clearance<30mL / min) 4) Patients with severe liver failure [AST (GOT) or ALT (GPT)>100 IU / L] 5) Patients with uncontrolled arrhythmias, hypotension (blood pressure <90 / 50mmHg), or uncontrolled high blood pressure (blood pressure> 170 / 100mmHg) 6) Fetus with chromosomal abnormality can be considered from ultrasonography 7) Retinitis pigmentosa patients 8) Patients with bleeding disorders or peptic ulcer 9) Patients with pulmonary venous occlusive disease 10) Patient is determined to be unsuitable as a study subject

研究者

发起方
Department of Obstetrics &amp; Gynecology Mie University Faculty of Medicine

相似试验